ENOV— Enovis CORP

Health Care$1.4B mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Net sales	$2.25B+6.7%	$2.11B+23.5%	$1.71B+9.2%	$1.56B
Cost of sales	$902.8M-2.6%	$926.9M+29.4%	$716.4M+3.3%	$693.7M
Gross profit	$1.35B+13.9%	$1.18B+19.2%	$990.8M+14.0%	$869.4M
Selling, general and administrative expense	$1.07B+4.2%	$1.03B+23.7%	$830.3M+7.4%	$772.9M
Research and development expense	$120.3M+31.8%	$91.3M+21.2%	$75.3M+23.8%	$60.8M
Amortization of acquired intangibles	$173.6M+4.9%	$165.5M+24.0%	$133.5M+5.7%	$126.3M
Purchase of royalty interest	$45.8M	$0	$0	—
Restructuring and other charges	$9.8M-64.1%	$27.3M+57.4%	$17.3M+0.6%	$17.2M
Goodwill impairment	$1.05B+62.8%	$645.0M	$0	$0
Operating loss	-$1.12B-44.9%	-$775.7M-1080.5%	-$65.7M+7.7%	-$71.2M
Interest expense, net	$34.8M-39.0%	$57.1M+189.1%	$19.7M-17.9%	$24.1M
Debt extinguishment charges	$0	$0-100.0%	$7.3M-64.0%	$20.4M
Other (income) expense, net	$367K+103.7%	-$9.9M+61.4%	-$25.7M-1129.1%	-$2.1M
Loss from continuing operations before income taxes	-$1.16B-40.9%	-$822.9M-1125.9%	-$67.1M-3144.5%	-$2.1M
Income tax expense (benefit)	$22.3M+396.3%	$4.5M+133.8%	-$13.3M-136.8%	$36.1M
Net loss from continuing operations	-$1.18B-42.8%	-$827.4M-1436.8%	-$53.8M-41.0%	-$38.2M
Income (loss) from discontinued operations, net of taxes	-$1.9M-173.4%	$2.6M-87.7%	$21.1M-20.1%	$26.4M
Net loss	-$1.18B-43.5%	-$824.8M-2420.0%	-$32.7M-178.3%	-$11.8M
Less: net income attributable to noncontrolling interest from continuing operations - net of taxes	$820K+20.8%	$679K+28.1%	$530K-6.5%	$567K
Net loss attributable to Enovis Corporation	-$1.18B-43.5%	-$825.5M-2381.9%	-$33.3M-150.2%	-$13.3M
Continuing operations - basic (in usd per share)	-$20720.00-38.3%	-$14980.00-1398.0%	-$1000.00-38.9%	-$720.00
Discontinued operations - basic	-$30-160.0%	$50-87.2%	$390-17.0%	$470
Consolidated operations - basic	-$21K-39.0%	-$15K-2347.5%	-$610-144.0%	-$250
Continuing operations - diluted (in usd per share)	-$20720.00-38.3%	-$14980.00-1398.0%	-$1000.00-38.9%	-$720.00
Discontinued operations - diluted	-$30-160.0%	$50-87.2%	$390-17.0%	$470
Consolidated operations - diluted	-$21K-39.0%	-$15K-2347.5%	-$610-144.0%	-$250

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 13 more years of annual history and full quarterly detail on Pro.

Upgrade to Pro →

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.